Review of TCM and Western Medicine Research on Assessment and Intervention of Elderly Frailty Click Copy

Review of TCM and Western Medicine Research on Assessment and Intervention of Elderly Frailty

References:

[1] 中华医学会老年医学分会.老年患者衰弱评估与干预中国专家共识[J].中华老年医学杂志,2017,36(3):251-256.

[2] 田鹏,杨宁,郝秋奎,等.中国老年衰弱患病率的系统评价[J].中国循证医学杂志,2019,19(6):656-664.

[3] 于普林,王建业.加强老年人衰弱综合征的防治研究[J].中华老年医学杂志,2015,34(12):1281.

[4] MA L, ZHANG L, TANG Z, et al. Use of the frailty index in evaluating the prognosis of older people in Beijing: a cohort study with an 8-year follow-up[J]. Arch Gerontol Geriatr,2016, 64:172-177.

[5] CUNHA A I L, VERONESE N, BORGES S D M, et al. Frailty as a predictor of adverse outcomes in hospitalized older adults:a systematic review and meta-analysis[J/OL]. Ageing Res Rev[2020-02-26].https://pubmed.ncbi.nlm.nih.gov/31518686/.

[6] HUBBARD R E, O’MAHONY M S, WOODHOUSE K W. Medication prescribing in frail older people[J]. Eur J Clin Pharmacol,2013,69(3):319- 326.

[7] MORLEY J E, VELLAS B, VAN KAN G A, et al. Frailty consensus: a call to action[J]. J Am Med Dir Assoc,2013,14(6):392-397.

[8] FRIED L P, TANGEN C M, WALSTON J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci,2001, 56(3):146-156.

[9] ROCKWOOD K. Frailty and its definition:a worthy challenge[J]. J Am Geriatr Soc,2005,53:1069-1070.

[10] GOBBENS R J, BOERSMA P, UCHMANOWIC I, et al. The Tilburg frailty indicator(TFI):new evidence for its validity[J]. Clin Interv Aging,2020,15:265-274.

[11] MORENO-ARIÑO M, JIMÉNEZ I T, GUTIÉRREZ A C, et al. Assessing the strengths and weaknesses of the Clinical Frailty Scale through correlation with a frailty index[J]. Aging Clin Exp Res,2020, 32(11):2225-2232.

[12] JANKOWSKA-POLAÑSKA B, UCHMANOWICZ B, KUJAWSKA-DANECKA H, et al. Assessment of frailty syndrome using Edmonton frailty scale in Polish elderly sample[J]. Aging Male,2019,22(3):177-186.

[13] ALQAHTANI B A, NASSER T A. Assessment of frailty in Saudi community-dwelling older adults:validation of measurements[J]. Ann Saudi Med,2019,39(3):197-204.

[14] BASSI D, SHANLEY C. Frailty in an older impatient population:using the clinical frailty scale to predict patient outcomes[J]. J Aging Health,2015,27(4):670-685.

[15] DANIELS R, ROSSUM E V, BEURSKENS A, et al. The predictive validity of three self-report screening instruments for identifying frail older people in the community[J]. BMC Public Health,2012,12:69.

[16] SALMINEN M, VILJANEN A, ELORANTA S, et al. Frailty and mortality:an 18-year follow-up study among Finnish community- dwelling older people[J/OL]. Aging Clin Exp Res[2020-02-26]. https://pubmed.ncbi.nlm.nih.gov/31654244/.

[17] KOHLER S, RAMETTA R, POULTER M, et al. Resilience, frailty and outcomes in geriatric rehabilitation[J]. Australas J Ageing, 2020,39(2):e205-e209.

[18] GOLDSTEIN J, HUBBARD R E, MOORHOUSE P, et al. The validation of a care partner-derived frailty index based upon comprehensive geriatric assessment (CP-FI-CGA) in emergency medical services and geriatric ambulatory care[J]. Age and Ageing,2015,44(2):327-330.

[19] SAMSON L D, BOOTS A M H, VERSCHUREN W M M, et al. Frailty is associated with elevated CRP trajectories and higher numbers of neutrophils and monocytes[J]. Exp Gerontol,2019,125:110674.

[20] 陈玉良.血清PCT及IL-6水平与老年衰弱的相关性研究[J].航空航天医学杂志,2019,30(2):129-132.

[21] 谢丰.老年人衰弱与左室舒张功能不全和N末端B型脑钠肽前体的相关性研究[D].南昌:南昌大学,2018.

[22] VALDIGLESIAS V, MARCOS-PÉREZ D, LORENZI M, et al. Immunological alterations in frail older adults:a cross sectional study[J]. Exp Gerontol,2018,112:119-126.

[23] MARCOS-PEREZ D, SANCHEZ-FLORES M, MASEDA A, et al. Frailty in older adults is associated with plasma concentrations of inflammatory mediators but not with lymphocyte subpopulations[J/OL]. Front Immunol[2020-02-26]. https://pubmed. ncbi.nlm.nih.gov/29868017/.

[24] BERTOLI A, VALENTINI A, CIANFARANI M A, et al. Low FT3:a possible marker of frailty in the elderly[J]. Clin Interv Aging, 2017,12:335-341.

[25] MATSUSHITA K, KURITA N, HORIE S. Relationships between testosterone value and frailty in aging men and women[J]. Eur Urol Suppl,2018,17(2):e303.

[26] LIN C H, LIAO C C, HUANG C H, et al. Proteomics analysis to identify and characterize the biomarkers and physical activities of non-frail and frail older adults[J]. Int J Med Sci,2017,14(3):231-239.

[27] 关欣,黄飞,闫小光,等.《中西医结合老年衰弱评估量表》的构建研究[J].北京中医药,2018,37(3):202-205,211.

[28] 乔琳琳,闫小光,黄飞,等.《中西医结合老年衰弱评估量表》的临床应用[J].北京中医药,2018,37(3):206-208.

[29] 李金辉,刘海华,李永杰,等.老年衰弱的中医证候探讨[J].北京中医药,2018,37(3):199-201.

[30] 刘亚楠.老年衰弱中医证型的分布规律研究[D].福州:福建中医药大学,2017.

[31] LIAO C D, LEE P H, HSIAO D J, et al. Effects of protein supplementation combined with exercise intervention on frailty indices, body composition, and physical function in frail older adults[J]. Nutrients,2018,10(12):1-32.

[32] MORLEY J E, MALMSTROM T K. Frailty, sarcopenia, and hormones[J]. Endocrinol Metab Clin North Am,2013,42(2):391-405.

[33] VERONESE N, STUBS B, SMITH L, et al. Angiotensin-converting enzyme inhibitor use and incident frailty:a longitudinal cohort study[J]. Drugs Aging,2019,36(4):387-393.

[34] SAAD F, RÖHRIG G, VON HAEHLING S, et al. Testosterone deficiency and testosterone treatment in older men[J]. Gerontology,2017, 63(2):144-156.

[35] 刘柳.基于中医理论探讨老年衰弱综合征[J].世界最新医学信息文摘,2019,19(8):232.

[36] 鲍晓敏,史晓,沈雁.从“肾”论治老年衰弱综合征[J].陕西中医, 2019,40(8):1098-1100.

[37] 张立,陈民,尹江涛,等.从先天和后天论治老年衰弱综合征[J].中华中医药学刊,2018,36(10):2543-2546.

[38] 洪秀芳,汤小芳,张学锋,等.补脾益肾法治疗老年衰弱患者的临床疗效及安全性研究[J].中华全科医学,2019,17(4):653-656.

[39] 章晓君,卢艳丽,王元利,等.中医体质辨识及调护用于老年综合评估的临床应用研究[J].中国医药导报,2016,13(35):131-133,146.

[40] 赵俊男,徐凤芹.中医药在老年衰弱多学科干预中的特点和优势[J]. 北京中医药,2018,37(3):212-214.

[41] 吕卫华,王青,赵清华,等.住院老年患者衰弱评估及不同衰弱评估工具的比较[J].北京医学,2016,38(10):1036-1040.

[42] 乔玉凤,刘学军,杜毓锋,等.基于照护者的老年综合评估衰弱指数问卷的汉化及信效度检验[J].中华老年病研究电子杂志,2016,3(3):16-23.

[43] 李菲,刘慧松,查龙肖,等.中文版老年人衰弱评估量表的修订和信效度评价[J].护理学杂志,2017,32(7):18-20,27.

Memo

基金项目:国家自然科学基金(81574036);北京市自然科学基金(7172094、7162079);北京市中西医结合协同机制建设专项(2016-10)